4//SEC Filing
RODRIGUEZ RAUL R 4
Accession 0000905148-25-000237
CIK 0001034842other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 8:49 PM ET
Size
13.3 KB
Accession
0000905148-25-000237
Insider Transaction Report
Form 4
RODRIGUEZ RAUL R
EVP, COO
Transactions
- Exercise/Conversion
Common Stock
2025-01-24$21.40/sh+45,000$963,000→ 250,584 total - Exercise/Conversion
Common Stock
2025-01-24$21.40/sh+45,000$963,000→ 249,662 total - Tax Payment
Common Stock
2025-01-24$22.17/sh−44,078$977,209→ 205,584 total - Tax Payment
Common Stock
2025-01-24$22.17/sh−44,078$977,209→ 206,506 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-01-24−45,000→ 0 totalExercise: $21.40From: 2016-04-04Exp: 2025-01-26→ Common Stock (45,000 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2025-01-24−45,000→ 0 totalExercise: $21.40Exp: 2025-01-26→ Common Stock (45,000 underlying)
Footnotes (3)
- [F1]These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.
- [F2]Includes 1,000 shares acquired under the Issuer's stock purchase plan.
- [F3]The shares vested monthly over two (2) years from January 1, 2015.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001190279
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 8:49 PM ET
- Size
- 13.3 KB